Health In Tech, Inc. — Form 8-K
Filed September 30, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 72/100
What the filing says
Health In Tech announced HitRix, an AI-powered platform for large-group self-funded health insurance workflows, launching across its 933-partner distribution network (19.9% YoY growth as of June 30, 2026). The company revised 2026 full-year revenue guidance to approximately $33 million, roughly flat versus 2025, citing timing of HitRix commercialization, a Three-Year Rate Stabilization Program, and carrier capacity expansion. Management expects these initiatives to contribute materially beginning in 2027.
Why this rating
New product launch + flat guidance are material for $12.7M market-cap firm. Growth deferred to 2027 is mixed signal; positive platform expansion, negative near-term momentum.
Price action (we called it neutral)
before filing · preread $0.87 | at our read pending | +10 min pending | +30 min pending | +1 hr pending | +4 hrs pending |
Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →
See more from September 30, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.